Biomarker directed treatment in metastatic colorectal cancer
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms AMGT-ERCC1
- 07 Jun 2017 Biomarkers information updated
- 21 Mar 2015 Planned number of patients changed from 30 to 50, according to European Clinical Trials Database record.
- 24 Oct 2012 Additional information source identified, ClinicalTrials.gov and integrated; Study centres added.